Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$3.24
+1.9%
$3.39
$2.77
$15.55
$192.22M0.832.38 million shs1.53 million shs
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$9.68
-0.6%
$9.32
$5.38
$11.04
$195.36M1.4171,088 shs84,730 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.05
+4.5%
$3.10
$2.66
$5.92
$50.21M1.0933,346 shs21,765 shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$0.92
-0.3%
$1.02
$0.70
$7.44
$166.82M1.942.03 million shs553,729 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
0.00%-3.28%+5.19%-63.39%-69.43%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%-4.72%+6.96%+3.20%+53.90%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-0.65%+12.55%-32.07%-33.55%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
0.00%-5.47%-3.62%-13.43%+91,759,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$3.24
+1.9%
$3.39
$2.77
$15.55
$192.22M0.832.38 million shs1.53 million shs
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$9.68
-0.6%
$9.32
$5.38
$11.04
$195.36M1.4171,088 shs84,730 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.05
+4.5%
$3.10
$2.66
$5.92
$50.21M1.0933,346 shs21,765 shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$0.92
-0.3%
$1.02
$0.70
$7.44
$166.82M1.942.03 million shs553,729 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
0.00%-3.28%+5.19%-63.39%-69.43%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%-4.72%+6.96%+3.20%+53.90%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-0.65%+12.55%-32.07%-33.55%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
0.00%-5.47%-3.62%-13.43%+91,759,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Embecta Corp. stock logo
EMBC
Embecta
1.40
Strong Sell$11.00239.51% Upside
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
2.67
Moderate Buy$15.0054.96% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.57
Moderate Buy$6.88125.41% Upside
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
2.00
Hold$8.00771.84% Upside

Current Analyst Ratings Breakdown

Latest SRTS, INFU, STEX, and EMBC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
Lower Price TargetBuy$9.00 ➝ $8.00
5/18/2026
Embecta Corp. stock logo
EMBC
Embecta
Lower Price TargetUnderperform$11.00 ➝ $3.00
5/8/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
5/8/2026
Embecta Corp. stock logo
EMBC
Embecta
DowngradeHoldStrong Sell
5/6/2026
Embecta Corp. stock logo
EMBC
Embecta
DowngradeHold (C-)Sell (D+)
5/6/2026
Embecta Corp. stock logo
EMBC
Embecta
Lower Price TargetNeutral$12.00 ➝ $5.00
5/5/2026
Embecta Corp. stock logo
EMBC
Embecta
DowngradeBuyNeutral
5/1/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
UpgradeSell (E+)Sell (D-)
4/21/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingSell (D)
4/13/2026
Embecta Corp. stock logo
EMBC
Embecta
Lower Price TargetNeutral$14.00 ➝ $12.00
(Data available from 7/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Embecta Corp. stock logo
EMBC
Embecta
$1.08B0.18$4.00 per share0.81($11.12) per share-0.29
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$142.40M1.37$0.76 per share12.79$2.47 per share3.92
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$22.53M2.23N/AN/A$2.93 per share1.04
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$40K4,170.49N/AN/A$0.83 per share1.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Embecta Corp. stock logo
EMBC
Embecta
$95.40M$1.901.711.85N/A10.73%-23.96%14.12%8/6/2026 (Estimated)
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$870K$0.38161.3631.23N/A1.12%2.78%1.41%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.47N/AN/AN/A-34.50%-15.79%-14.02%8/6/2026 (Estimated)
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/A

Latest SRTS, INFU, STEX, and EMBC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q3 2026
Embecta Corp. stock logo
EMBC
Embecta
$0.26N/AN/AN/A$254.53 millionN/A
8/6/2026Q2 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250N/AN/AN/A$4.60 millionN/A
5/14/2026Q1 2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A-$0.27N/A-$0.27N/AN/A
5/7/2026Q1 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.16-$0.0350-$0.16$5.32 million$3.39 million
5/5/2026Q2 2026
Embecta Corp. stock logo
EMBC
Embecta
$0.42$0.27-$0.15-$0.07$235.67 million$221.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Embecta Corp. stock logo
EMBC
Embecta
$0.041.23%N/A2.11%N/A
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/AN/AN/AN/AN/A

Latest SRTS, INFU, STEX, and EMBC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2026
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.011.2%5/28/20265/28/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.46
1.68
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.50
1.98
1.59
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
7.27
4.03
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A
13.90
13.90

Institutional Ownership

CompanyInstitutional Ownership
Embecta Corp. stock logo
EMBC
Embecta
93.83%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
71.13%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
7.16%

Insider Ownership

CompanyInsider Ownership
Embecta Corp. stock logo
EMBC
Embecta
1.30%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
10.80%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
52.73%
CompanyEmployeesShares OutstandingFree FloatOptionable
Embecta Corp. stock logo
EMBC
Embecta
1,85059.33 million58.56 millionOptionable
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
41020.18 million19.10 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.46 million14.78 millionOptionable
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
50181.80 million85.94 millionN/A

Recent News About These Companies

Streamex Corp. Provides May 2026 Shareholder Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Embecta stock logo

Embecta NASDAQ:EMBC

$3.24 +0.06 (+1.89%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$3.27 +0.03 (+0.93%)
As of 07/10/2026 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

InfuSystem stock logo

InfuSystem NYSE:INFU

$9.68 -0.06 (-0.62%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$9.68 0.00 (-0.05%)
As of 07/10/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.05 +0.13 (+4.45%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$3.06 +0.01 (+0.16%)
As of 07/10/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Biosig Technologies stock logo

Biosig Technologies NASDAQ:STEX

$0.92 0.00 (-0.26%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$0.90 -0.02 (-2.14%)
As of 07/10/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.